TABLE 5.
Route of administration | Dose (mg/kg) | Cmax (μg/mL) | Tmax (h) | t1/2 (h) | CLba (mL/min/kg) | CLub (mL/min/kg) | Vss (liters/kg) | AUC0–∞c (h· μg/mL) | Fd (%) |
---|---|---|---|---|---|---|---|---|---|
i.v. | 2 | 3.7 | 14.3 | 210 | 5.1 | 2.37 | |||
p.o. | 20 | 9.5 | 1.0 | 24.6 | 104 | ||||
p.o. | 100 | 47 | 2.8 | 343 | |||||
p.o. | 300 | 133 | 1.0 | 1271 | |||||
p.o. | 500 | 117 | 0.83 | 1435 |
Blood clearance.
Unbound clearance based on PPB = 93.2%.
Area under the curve.
Oral bioavailibility.
Tmax, time to maximum concentration of drug in serum; t1/2, half-life. Vss, volume at steady state.